Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-07

FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Inderal LA (propranolol hydrochloride) by ANI Pharmaceuticals, Inc. The action confirms regulatory approval related …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INDERAL LA (Propranolol hydrochloride)

Snippet

SUPPL AP for INDERAL LA (PROPRANOLOL HYDROCHLORIDE)